Gastrointestinal hormone upon their chemical structure. Ghrelin is a peptide hormone released from the stomach and liver and is often referred to as the "hunger hormone" since high levels of it are found in individuals that are fasting. Ghrelin agonistic treatments can be used to treat illnesses such as anorexia and loss of appetites in cancer patients. Ghrelin treatments for obesity are still under intense scrutiny and no conclusive evidence has been reached. This hormone stimulates growth hormone release. Amylin controls glucose homeostasis and gastric motility Glucose-dependent insulinotropic polypeptide possesses an acute influence on food intake through its effects on adipocytes Oxyntomodulin
Growth hormone and extracted from carcasses. Hormone extracted from human cadavers is abbreviated "hGH". The main growth hormone produced by recombinant DNA technology has the approved generic name (INN) "somatropin" and the brand name "Humatrope", and is properly abbreviated rhGH in the scientific literature. Since its introduction in 1992 Humatrope has been a banned sports doping agent, and in this context is referred to as HGH. Genes for human growth hormone, known as growth hormone 1 (somatotropin; pituitary growth hormone) and growth hormone 2 (placental growth hormone; growth hormone variant), are localized in the q22-24 region of chromosome 17 and are closely